Table 2.

Muscle biopsy score breakdown for patients with anti-HMGCR. Biopsy appearances were consistent with a destructive myopathy with high scores in the muscle fiber domain. All biopsies had evidence of inflammation. Muscle biopsies were analyzed using the JDM muscle biopsy score tool as previously described by Wedderburn, et al8,9.

VariablesPatient 1Patient 2Patient 3Patient 4
Any treatment prebiopsy?NoYesNoYes
Inflammatory domain
  CD3+ endomysial infiltration, 0–22No tissue available for histological reassessment. a21
  CD3+ perimysial infiltration, 0–2010
  CD3+ perivascular infiltration, 0–2220
  CD68+ endomysial infiltration, 0–2221
  CD68+ perimysial infiltration, 0–2121
  CD68+ perivascular infiltration, 0–2221
  Domain total9114
Vascular domain
  Capillary dropout, 0–1000
  Arterial abnormality, 0–1000
  Infarction, 0–1000
  Domain total000
Muscle fiber domain
  MHC I over-expression, 0–1110
  Perifascicular atrophy221
  Neonatal myosin, 0–1111
  Fiber atrophy, 0–1110
  Regeneration/degeneration/necrosis perifascicular222
  Regeneration/degeneration/necrosis nonperifascicular222
  Internal myonuclei in nonbasophilic otherwise normal fibers, 0–1111
  Domain total10107
Connective tissue domain
  Any endomysial fibrosis, 0–1111
  Any perimysial fibrosis, 0–1010
  Domain total121
Total score, 0–27202312
VAS severity, 0–10797
MAC (C5-9b) staining of necrotic fibersYesYesYes
  • Significant data are in bold face.

  • a Original muscle biopsy report comments on muscle fiber necrosis and inflammation. Biopsy findings were considered supportive of a diagnosis of a myositis in the correct clinical context, but not diagnostic on their own. Anti-HMGCR: anti-HMG-CoA-reductase; JDM: juvenile dermatomyositis; VAS: visual analog scale; MAC: membrane attack complex.